Sign in to view content

Real-world U.S. outcomes of anti-VEGF therapy in diabetic macular edema

Thomas A. Ciulla, MD, MBA, FASRS

Video
Published 2017

Related

Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: One-Year Primary Outcomes From the Randomized RECOVERY Trial
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2019
Brolucizumab in HAWK/HARRIER: Outcomes, Efficacy, & Dosing Status – Everything You Need to Know!
David M. Brown, MD
Updates from the Field
2018
Distribution and Practice Patterns of Retina Providers across the United States
Ravi R Pandit, M.D., M.P.H.
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more